OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

2025 Tolley Team fundraising for Duchenne UK

Marie Hutchinson, Office Manager
August 2025

This summer, members of the Tolley team have undertaken a series of sporting events including the Lake District and Peak District Ultra Challenges, the Yr Wyddfa (Snowdon) 24-hour challenge, and a 24-hour sponsored gym event in collaboration with our local gym, with the aim of raising at least £3,000. The total currently sits at over £3,500.

The team at Tolley place empahsis on enhancing the patient voice by supporting patient organisations related to the work we have conducted, whilst trying to keep fit at the same time. This years’ chosen charity was Duchenne UK, the leading UK charity supporting families living with Duchenne muscular dystrophy (DMD), following our involvement with Project HERCULES, a ground breaking multinational collaboration set up by Duchenne UK to develop tools and evidence to support Health Technology Assessments and reimbursement decisions for new treatments for DMD. You can view our Research Paper on ‘The personal and health service impact of side-effects of long-term corticosteroid use in the treatment of Duchenne Muscular Dystrophy in the UK: A qualitative study’ by signing up to our Research Insights Series via the Our research page of our website.

Register to access the Tolley insights